E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers A > Headlines for Angiotech Pharmaceuticals, Inc. > News item
Published on 6/25/2009 in the Prospect News Bank Loan Daily, Prospect News Distressed Debt Daily and Prospect News High Yield Daily.

S&P may upgrade Angiotech

Standard & Poor's said it placed the CC long-term corporate credit rating on Angiotech Pharmaceuticals Inc. on CreditWatch with positive implications.

"The CreditWatch placement reflects our view that Angiotech's liquidity position has improved sufficiently to enable the company to continue operations in the near term," S&P analyst Lori Harris said in a statement.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.